Structural changes of the ligand and of the receptor alters the receptor preference for neutrophil activating peptides starting with a formylmethionyl group

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 1, 2015, Pages 192-200

  Forsman, Huamei ^a   Winther, Malene ^a   Gabl, Michael ^a   Skovbakke, Sarah Line ^a,b   Boulay, Francois ^c,d,e,f   Rabiet, Marie Josèphe ^c,d,e,f   Dahlgren, Claes ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c CEA GRENOBLE   (France)

^d INSERM   (France)

^e UNIV GRENOBLE ALPES   (France)

^f CNRS   (France)

Author keywords

Formyl peptide; G protein coupled receptor; Inflammation; Neutrophil

Indexed keywords

BACTERIAL PROTEIN; FMILFL PSM 5 16 PEPTIDE; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; FORMYLPEPTIDE RECEPTOR LIKE 2; LIGAND; PSMALPHA2 1 10 PEPTIDE; PSMALPHA2 1 16 PEPTIDE; PSMALPHA2 1 5 PEPTIDE; PSMALPHA2 PEPTIDE; UNCLASSIFIED DRUG; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FPR1 PROTEIN, HUMAN; FPR2 PROTEIN, HUMAN; LIPOXIN RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; LEUKOCYTE ACTIVATION; LIGAND BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; AGONISTS; CHEMISTRY; DRUG EFFECTS; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

HUMANS; LIGANDS; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHIL ACTIVATION; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84909957893     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.10.021     Document Type: Article

References (36)

1. Rabiet M.J., Huet E., Boulay F. Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur. J. Immunol. 2005, 35:2486-2495.
2. Rabiet M.J., Huet E., Boulay F. The N-formyl peptide receptors and the anaphylatoxin C5a receptors: an overview. Biochimie 2007, 89:1089-1106.
3. Pittman K., Kubes P. Damage-associated molecular patterns control neutrophil recruitment. J. Innate Immun. 2013, 315-323.
4. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., Brohi K., Itagaki K., Hauser C.J. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010, 464:104-107.
5. Ye R.D., Boulay F., Wang J.M., Dahlgren C., Gerard C., Parmentier M., Serhan C.N., Murphy P.M. International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 2009, 61:119-161.
6. Fu H., Karlsson J., Bylund J., Movitz C., Karlsson A., Dahlgren C. Ligand recognition and activation of formyl peptide receptors in neutrophils. J. Leukoc. Biol. 2006, 79:247-256.
7. McDonald B., Pittman K., Menezes G.B., Hirota S.A., Slaba I., Waterhouse C.C., Beck P.L., Muruve D.A., Kubes P. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 2010, 330:362-366.
8. Kolaczkowska E., Kubes P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 2013, 13:159-175.
9. Southgate E.L., He R.L., Gao J.L., Murphy P.M., Nanamori M., Ye R.D. Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils. J. Immunol. 2008, 181:1429-1437.
10. Miettinen H.M., Mills J.S., Gripentrog J.M., Dratz E.A., Granger B.L., Jesaitis A.J. The ligand binding site of the formyl peptide receptor maps in the transmembrane region. J. Immunol. 1997, 159:4045-4054.
11. Gao J.L., Murphy P.M. Species and subtype variants of the N-formyl peptide chemotactic receptor reveal multiple important functional domains. J. Biol. Chem. 1993, 268:25395-25401.
12. Quehenberger O., Prossnitz E.R., Cavanagh S.L., Cochrane C.G., Ye R.D. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors. J. Biol. Chem. 1993, 268:18167-18175.
13. Movitz C., Brive L., Hellstrand K., Rabiet M.J., Dahlgren C. The annexin I sequence gln(9)-ala(10)-trp(11)-phe(12) is a core structure for interaction with the formyl peptide receptor 1. J. Biol. Chem. 2010, 285:14338-14345.
14. Mills J.S., Miettinen H.M., Cummings D., Jesaitis A.J. Characterization of the binding site on the formyl peptide receptor using three receptor mutants and analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu. J. Biol. Chem. 2000, 275:39012-39017.
15. Sklar L.A., Fay S.P., Seligmann B.E., Freer R.J., Muthukumaraswamy N., Mueller H. Fluorescence analysis of the size of a binding pocket of a peptide receptor at natural abundance. Biochemistry 1990, 29:313-316.
16. Kretschmer D., Gleske A.K., Rautenberg M., Wang R., Koberle M., Bohn E., Schoneberg T., Rabiet M.J., Boulay F., Klebanoff S.J., van Kessel K.A., van Strijp J.A., Otto M., Peschel A. Human formyl peptide receptor 2 senses highly pathogenic Staphylococcus aureus. Cell Host Microbe 2010, 7:463-473.
17. Rautenberg M., Joo H.S., Otto M., Peschel A. Neutrophil responses to staphylococcal pathogens and commensals via the formyl peptide receptor 2 relates to phenol-soluble modulin release and virulence. FASEB J. 2011, 25:1254-1263.
18. Forsman H., Christenson K., Bylund J., Dahlgren C. Receptor-dependent and -independent immunomodulatory effects of phenol-soluble modulin peptides from Staphylococcus aureus on human neutrophils are abrogated through peptide inactivation by reactive oxygen species. Infect. Immun. 2012, 80:1987-1995.
19. Forsman H., Andreasson E., Karlsson J., Boulay F., Rabiet M.J., Dahlgren C. Structural characterization and inhibitory profile of formyl peptide receptor 2 selective peptides descending from a PIP2-binding domain of gelsolin. J. Immunol. 2012, 189:629-637.
20. Dahlgren C., Christophe T., Boulay F., Madianos P.N., Rabiet M.J., Karlsson A. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor. Blood 2000, 95:1810-1818.
21. Boyum A., Lovhaug D., Tresland L., Nordlie E.M. Separation of leucocytes: improved cell purity by fine adjustments of gradient medium density and osmolality. Scand. J. Immunol. 1991, 34:697-712.
22. Bylund J., Bjornsdottir H., Sundqvist M., Karlsson A., Dahlgren C. Measurement of respiratory burst products, released or retained, during activation of professional phagocytes. Methods Mol. Biol. 2014, 1124:321-338.
23. Dahlgren C., Karlsson A., Bylund J. Measurement of respiratory burst products generated by professional phagocytes. Methods Mol. Biol. 2007, 412:349-363.
24. Bjorstad A., Askarieh G., Brown K.L., Christenson K., Forsman H., Onnheim K., Li H.N., Teneberg S., Maier O., Hoekstra D., Dahlgren C., Davidson D.J., Bylund J. The host defense peptide LL-37 selectively permeabilizes apoptotic leukocytes. Antimicrob. Agents Chemother. 2009, 53:1027-1038.
25. Christenson K., Bjorkman L., Tangemo C., Bylund J. Serum amyloid A inhibits apoptosis of human neutrophils via a P2X7-sensitive pathway independent of formyl peptide receptor-like 1. J. Leukoc. Biol. 2008, 83:139-148.
26. Karlsson J., Stenfeldt A.L., Rabiet M.J., Bylund J., Forsman H.F., Dahlgren C. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels. Cell Calcium 2009, 45:431-438.
27. Stenfeldt A.L., Karlsson J., Wenneras C., Bylund J., Fu H., Dahlgren C. The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1. Biochem. Pharmacol. 2007, 74:1050-1056.
28. Schepetkin I.A., Khlebnikov A.I., Giovannoni M.P., Kirpotina L.N., Cilibrizzi A., Quinn M.T. Development of small molecule non-peptide formyl peptide receptor (FPR) ligands and molecular modeling of their recognition. Curr. Med. Chem. 2014, 1478-1504.
29. Christophe T., Karlsson A., Dugave C., Rabiet M.J., Boulay F., Dahlgren C. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2. J. Biol. Chem. 2001, 276:21585-21593.
30. Le Y., Gong W., Li B., Dunlop N.M., Shen W., Su S.B., Ye R.D., Wang J.M. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J. Immunol. 1999, 163:6777-6784.
31. Cheung G.Y., Kretschmer D., Queck S.Y., Joo H.S., Wang R., Duong A.C., Nguyen T.H., Bach T.H., Porter A.R., DeLeo F.R., Peschel A., Otto M. Insight into structure-function relationship in phenol-soluble modulins using an alanine screen of the phenol-soluble modulin (PSM) alpha3 peptide. FASEB J. 2014, 28:153-161.
32. He H.Q., Troksa E.L., Caltabiano G., Pardo L., Ye R.D. Structural determinants for the interaction of formyl peptide receptor 2 with peptide ligands. J. Biol. Chem. 2014, 289:2295-2306.
33. Quehenberger O., Pan Z.K., Prossnitz E.R., Cavanagh S.L., Cochrane C.G., Ye R.D. Identification of an N-formyl peptide receptor ligand binding domain by a gain-of-function approach. Biochem. Biophys. Res. Commun. 1997, 238:377-381.
34. Le Y., Ye R.D., Gong W., Li J., Iribarren P., Wang J.M. Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis. FEBS J. 2005, 272:769-778.
35. Bena S., Brancaleone V., Wang J.M., Perretti M., Flower R.J. Annexin A1 interaction with the FPR2/ALX receptor: identification of distinct domains and downstream associated signaling. J. Biol. Chem. 2012, 287:24690-24697.
36. Forsman H., Bylund J., Oprea T.I., Karlsson A., Boulay F., Rabiet M.J., Dahlgren C. The leukocyte chemotactic receptor FPR2, but not the closely related FPR1, is sensitive to cell-penetrating pepducins with amino acid sequences descending from the third intracellular receptor loop. Biochim. Biophys. Acta 2013, 1833:1914-1923.